Lokteva L. M.1, Ibadullaeva N. S.1, Sattarova D. H.2, Aripova G. M.3, Pulatova R. Z.1, Alieva L. E.1, Musabaev E. I.1
1Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan
2Department of Pediatric Infectious Diseases, Tashkent Pediatric Medical Institute, Master's Degree, Tashkent, Uzbekistan
3Clinic of the Tashkent Pediatric Medical Institute, Department of Cardiorheumatology, Tashkent, Uzbekistan
Correspondence to: Lokteva L. M., Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan.
Email: | |
Copyright © 2020 The Author(s). Published by Scientific & Academic Publishing.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
Abstract
In Uzbekistan, it is a first ever study of B19 parvovirus, its clinical manifestations are known poorly. This article is devoted to the study of clinical symptoms and laboratory changes with parvovirus B19 infection in children in the period of the rise of infectious erythema. From January to December 2019, a comprehensive examination of 28 children was conducted. In the investigation of blood serum IgM antibodies to parvovirus B19 ELISA result was positive. At the age from 6 months to 35 years. Established the development of the disease mainly in children of preschool and early school age, more often in boys, with the seasonal rise in April and May. Parvovirus infection has a benign course.
Keywords:
Parvovirus infection, Rash, Children, IgM antibodies
Cite this paper: Lokteva L. M., Ibadullaeva N. S., Sattarova D. H., Aripova G. M., Pulatova R. Z., Alieva L. E., Musabaev E. I., Clinical and Laboratory Features of Manifestation of Parvovirus Infection in Children, American Journal of Medicine and Medical Sciences, Vol. 10 No. 4, 2020, pp. 183-186. doi: 10.5923/j.ajmms.20201004.01.
1. Introduction
There are a number of non-diagnosable conditions that have various clinical masks of both infectious and somatic diseases. Differential diagnosis of these infections is of great epidemiological and clinical importance, since without the correct diagnosis it is impossible to organize epidemiological surveillance and prescribe the correct treatment in each case. Infectious pathology accompanied by acute exanthema presents significant difficulties in the differential diagnosis of other diseases. One of the diseases occurring with a rash is parvovirus infection B19.Parvovirus B19 infection ("fifth disease", infectious erythema) is a common disease worldwide, occurring predominantly in children [5]. The virus belongs to the family Parvoviridae, the genus Erythrovirus [1]. Manifestations of infection depend on the immunological and hematological characteristics of the macroorganism [3]. In the international classification of diseases of the tenth revision (ICD-10), parvovirus infection has the codes: B08.3 - erythema infectious (fifth disease); B97.6 - Parvoviruses as the cause of diseases classified elsewhere; B34.3 - unspecified parvovirus infection. [6]. In 1995, the pathogen was classified as erythrovirus due to its tropism for erythrocyte precursors in the bone marrow and spleen, on the surface of which there is a P-antigen - a membrane receptor that facilitates the penetration of the virus into the cells. [12]. Further, its expression on the surface of mature red blood cells, megakaryocytes, granulocytes, endothelial and smooth muscle cells of blood vessels, hepatocytes and other cells is proved [2].In immunocompetent individuals without hematologic disorders, inhibition of erythropoiesis due to virus replication is subclinical or asymptomatic. In the dynamics of the disease, in addition to anemia, thrombocytopenia may develop. This is especially true for newborns and patients with immunodeficiency. [9].Along with typical acquired clinical forms of parvovirus infection (acute and chronic), atypical (subclinical and asymptomatic), as well as intrauterine parvovirus infection are distinguished [4]. Infectious erythema or “fifth disease” is the most common typical acute clinical form in children. Despite the modern laboratory possibilities of verification of infectious diseases occurring with exanthema syndrome, etiological decoding is rarely carried out, which leads to underdiagnosis, in particular, parvovirus infection [7].In Uzbekistan, until 2019 there were no studies on this issue. Below is a clinical case that demonstrates a certain difficulty in making a clinical diagnosis of “Parvovirus infection” by primary care physicians, rheumatologists and allergists, which contributed to the incorrect diagnosis of this disease.The aim of the work: Determine the main clinical and laboratory features of the manifestation of parvovirus infection caused by the B19 virus in children of different ages.
2. Materials and Methods
The study was conducted at the Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan. The study is supported by an applied grant (PZ-2017090828) under the Ministry of Innovative Developments and the Ministry of Health. In order to select patients with suspected parvovirus infection, we have drawn up an agreement with City Children's Hospital №1 and the Tashkent Pediatric Medical Institute, clinic with the department of cardiac rheumatology. For the period March-December 2019, 144 samples with a suspected parvovirus infection were collected, of which 28 blood serum for IgM antibodies to parvovirus B19 by enzyme immunoassay (ELISA) was positive. Detection of IgM for parvovirus B19 was performed using the recomWellParvovirusB19 IgMs test system (MICROGEN, Germany) by ELISA in the Reference Laboratory of the Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan.
3. Results and Their Analysis
Diagnosis of parvovirus infection is a particular problem since this infection has clinical masks of both infectious and somatic diseases. Patients with parvovirus infection with rashes, joint pain, and a sharp decrease in hemoglobin can be treated with other diagnoses in allergology, rheumatology and hematology departments. Analysis of literature data shows that the etiology of 55-60% of allergic rashes remains unclear [8]. We studied 98 blood samples in patients with rashes who were hospitalized in the allergology department of the City Clinical Hospital-1 in Tashkent. The results of serological research showed the detection of IgM for parvovirus B19 in blood in 19 (19.4%) patients. In patients in the cardiac rheumatology department of TashPMI, IgM to parvovirus B19 was detected in 9 (19.5%) patients out of 46 patients with suspected parvovirus infection. In total, out of 144 patients, 28 are positive for parvovirus infection, which accounted for 19.4% of cases; parvovirus infection was detected in patients in somatic hospitals and receiving treatment under other diagnoses.Detection of IgM for parvovirus B19 using ELISA made it possible to unequivocally talk about the role of parvovirus in the development of infectious erythema, aplastic hemolytic anemia and arthralgia in the acute stage. All blood samples were obtained on the 3-4th day of hospitalization of the patient, which made it possible to make a final diagnosis of “parvovirus infection”, prescribe the appropriate therapy and cancel antibacterial treatment in unclear diagnostic cases.In determining the age characteristics of the 28 patients who had to identify IgM to parvovirus B19 most involved in the epidemic process were preschool and school age children (4 to 18 years) - 24 children (85,7% ± 1,4). Of these, preschool age (from 4 to 6 years) - 6 children (21.4% ± 4.2), schoolchildren (from 7 to 18 years) -16 children (57.1% ± 4.2). At the same time, there were only two children under the age of 1 to 3 years old (0.71% ± 4.2). Patients aged 19 years and older accounted for 14.2% ± 8.5 cases (4 patients) (table 1). Our results are consistent with literature, where children of preschool and school age are most often affected by parvovirus infection. [10].Table 1. Distribution of patients with parvovirus infection by age and gender |
| |
|
The distribution of patients by gender showed the identification of parvovirus infection among boys in 54.1% of cases, and among girls in 45.8% of cases, which corresponds to the data obtained by other authors [11].Parvovirus B19 infection occurred in mild form in 4 patients (14.2% ± 8.5) and 24 (85.7% ± 1.4) patients in moderate form (p <0.05). We have not noted severe forms of the disease. In patients with moderate disease, there was an increase in body temperature to 38.8°C, weakness, dizziness, drowsiness, loss of appetite, myalgia, catarrhal symptoms and rashes appeared on 3-4 days. 6 (21.4% ± 4.2) patients had pain in the knee joints. Character rash was varied: 24 in 19 children (79,1 %% ± 46,6) children marked hyperemia cheeks ("symptom Spanked cheeks") (Figure 1), spotty-papular character of rashes with localization on the upper, lower extremities, both on the flexor and extensor surfaces, the trunk, which in dynamics acquired a “lace” character (p <0.05) (Figure 2). | Figure 1. Symptom of «spanked cheeks» |
| Figure 2. Lace rash |
In 11 (45.8% ± 8.3) patients, the rash was hemorrhagically petechial in nature, mainly with a spotted rash spreading throughout the body (Figure 3) on the background of hyperemia of the cheeks. | Figure 3. Spotted rash all over the body |
Common small-spotted, pale pink rashes without local thickening were noted in 3 (10.7% ± 1.4) children. In 8 (28.5% ± 7.1) children, the rash persisted for 3-4 days. In 13 (46.4% ± 2.8) children, the rash lasted from 4 to 6 days (p <0.05) and 6-8 days in 2 (0.71% ± 4.2) children. The average rash duration was 6.0±1.5 days. The elements of the rash were both true spots that were not felt by the fingers, and had slightly elevated above the level of healthy skin. The rash caused itching, especially on the soles of the feet. In case of parvovirus infection, rubella, measles, and vesicular skin rashes have been described in literature (Cunha BA, Chandrankunnel J) [8]. And this is not uncommon. Suffice it to recall that in 1889, Anton Tshamer described this infection as one of the rubella variants. In our observations, a rash-like rash was observed in 21% of cases.When studying laboratory parameters of a general blood test, the following changes in the acute period of the disease were revealed: a 100% decrease in hemoglobin, leukopenia with a minimum white blood cell count of up to 2.6x109/l in 43.2% (n = 19) of patients. More than half of patients had normocytosis of 52.3% (n=23) with an average leukocyte value of 6.7 ± 0.8 x 109/l. Only 2 patients had leukocytosis: in one child, leukocytes reached 12.4 x 109/l, in the second - 20.4 x 109/l. Lymphocytosis was detected in 1/3 of patients (22.7%). Thrombocytopenia was observed in 60.7% (n=17) patients, an increase in ESR - in 22.7% (n=10) cases. Six (21.4%) patients had a positive C-reactive protein of 9 g/L and antistreptolysin O of 300 IU/ml (ASL O). In all children, an improvement in the general condition was noted on 4 ± 1.5 days after the rash.Patients were prescribed symptomatic treatment. If necessary, antipyretic drugs were prescribed (paracetamol, ibuprofen), NSAIDs to reduce joint pain. In case of aplastic crises and chronic anemia - transfusion of erythromass and intravenous administration of immunoglobulins.
4. Conclusions
Parvovirus infection is a common pathology in the world, which is confirmed by various authors. Nevertheless, despite the high prevalence of this infection in our Republic, a diagnosis of parvovirus infection is not made. Parvovirus infection is of great practical importance and can be used in any healthcare sector and will contribute to the timely diagnosis of this infection, namely the formulation of an etiological diagnosis. Parvovirus infection mainly affects preschool children (84% in our observation) and adults. The disease proceeds mainly in the middle form in children, has a characteristic picture of the development of a rash - the form of infectious erythema with the symptom of “spanked” cheeks with transformation into a lace rash without symptoms of intoxication and damage to other organs and systems. Also, all patients have thrombocytopenia and a decrease in hemoglobin, which is characteristic of parvovirus B19.
References
[1] | Belan Yu.B., Starikovich M.V. Parvovirus infection B19. Therapist, 2014; 01(14): 51-54. Rus |
[2] | Parvovirus infection / V.A. Anokhin [et al.] // Infectious Diseases. - 2010. - № 1. -С. 73-76. Rus |
[3] | Parvovirus (B 19V) infection in pregnant women and young children / A.Yu. Antipova [et al.] // Journal of Infectology. - 2011. - Т. 3, № 4. - С. 26-33. Rus |
[4] | The spread of parvovirus infection in the northwestern federal district of Russia / A.Yu. Antipova [et al.] // Journal of Infectology.- 2011. - Т. 3, № 4. - С. 44-48. Rus |
[5] | Anderson M. J., Jones S. E., Fisher-Hoch S. P. et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)//Lancet. 1983; 1: 1378. |
[6] | Brown K.E, Hibbs J.R, Gallinella G, Anderson S.M, Lehman E.D, McCarthy P, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330: 1192-6. poietic cells. J. Virol., 2001, 75: 4110-6. |
[7] | Clinical presentations of parvovirus B 19 infection / J.T. Servey [etal.] // American Family Physician. - 2007. - V. 75, № 3. - P.373-376. |
[8] | Cunha BA, Chandrankunnel J. Parvovirus B19 with a scarlatiniform/rubelliform rash and small joint arthritis mimicking rubella in an adult. Travel Med Infect Dis. 2012 Jul; 10(4): 208. |
[9] | Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period / M.J. Anderson [etal.] // J. Clin Pathol. - 1982.- V. 35. - P. 744-749. |
[10] | Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: a review. ActaVirol. 2014; 58(3): 199-213. |
[11] | Sharada Raju R, NaliniVinayak K, Madhusudan Bapat V, PreetiBalkisanji A, ShailaChandrakant P. Acute human parvovirus B19 infection: cytologic diagnosis. Indian J Hematol Blood Transfus. 2014; 30(Suppl. 1): 133-4. |
[12] | Weigel-Kelley KA, Yoder MC, Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cell. J. Virol 2001, 75: 4110-4116. |